Global stock

NASDAQUSD

Braze Inc.

BRZE

AI analysis and articles are in Czech.

§ Financial healthLong-term stability

56/ 100

Overall score·BRZE

Current price

45.84USD

26/10/2026

P/E, P/B

Valuation

Neutral

Rates whether the stock is cheap or expensive relative to its history and sector. A score above 60 suggests the stock trades below its estimated intrinsic value.

Tracks:P/E · P/B · FCF yield · sector

Forward P/E 30,6 a P/S 4,1 odrážejí růstová očekávání, ale ztrátovost a záporné EV/EBITDA ztěžují obhajobu valuace. Růst tržeb o 26,2 % a cena nad 50denním i 200denním průměrem jsou silnější stránky, zatímco slabou stránkou zůstává ziskovost a zvýšená governance rizika.

§ Outlook vs S&P 500Next 12 months

About the same

Estimated chance of beating the index: about 52%

8 of 8 inputs

NoProbably notSameProbably yesYes

A model estimate from current values. The result may change with new data; it is not a price target or an investment recommendation.

§ Financial results

Financial results·BRZE

M USD

RevenueEBITDANet incomeEBITDA margin

Margins and profitability·BRZE

Net marginEBITDA marginDashed = estimate

Net margin

-17.8 %

FY 2026 · reported

EBITDA margin

-17.0 %

FY 2027 · estimate

Net margin

-13.6 %

last 12 months

Operating margin

-8.0 %

last 12 months

ROE

-18.5 %

last 12 months

FY = fiscal year · TTM = trailing 12 months

§ Context and events

Management

V dodaném přehledu vedení jsou Astha Malik, Chief Business Officer, Edward McDonnell, Chief Revenue Officer, Nicholas Rockwell, Chief Information Officer, a Christopher L. Ferris, Head of Investor Relations. Strategie společnosti stojí na rozvoji cloudové platformy pro personalizovanou komunikaci se zákazníky a na růstu u firemních klientů.

Articles about Braze Inc., in Czech (1)

Salesforce kupuje Braze za 5,66 miliardy dolarů kvůli personalizaci

Salesforce uzavřel dohodu o převzetí Braze za přibližně 5,66 miliardy dolarů; akcionáři třídy A mají dostat 47,50 dolaru v hotovosti za akcii. Dokončení se očekává ve fiskálním roce 2028 po schválení akcionáři a regulátory.

21 October 2026· 3 min

§ Upcoming results

8 December 2026

in 42 days

Earnings

Earnings = quarterly financial results (revenue and profit). Companies publish them every three months and the share price often reacts strongly.

§ Frequently asked questions

What is Braze Inc. (BRZE)?

Braze Inc. (BRZE) is a global stock traded on NASDAQ. We track it daily — scoring news sentiment, the short-term outlook and long-term stability on a 0–100 scale.

What is the Braze Inc. price today?

As of 26 October 2026, Braze Inc. trades at about 45.84 USD per unit. We update the price daily from public market data. Intraday moves can differ significantly — always check the final price with your broker.

How to buy Braze Inc.?

Through regulated online brokers such as Degiro, XTB, Trading 212 or Interactive Brokers. Shares trade in USD or EUR — most brokers convert your currency automatically. FinSignal does not operate any of these platforms and charges no commission — the overview is only a signpost.

Does Braze Inc. pay a dividend?

Braze Inc. either pays no dividend at the moment or we have no reliable data on it. Many growth companies prefer reinvesting profit to paying dividends — check the current policy in the company's investor relations materials.

Is Braze Inc. a good investment in 2026?

Our AI signal currently rates Braze Inc. as slightly positive (score 59/100). Financial health comes out at 56/100, so beyond short-term news it is worth watching the valuation, growth, profitability and stability of the company. FinSignal is not an investment adviser licensed under Czech Act No. 256/2004 Coll. — signals are analytical input, not a recommendation to buy or sell. You make every decision at your own risk.

§ More global stocks

Microsoft Corporation

Advanced Micro Devices

§ How to buy Braze Inc.

You can buy shares through regulated online brokers available in the EU. They differ mainly in fees, app quality and which markets they cover.

Degiro
Dutch broker with low fees for passive investors. No account fee, trading in EUR and USD.
XTB
Polish broker with zero commission on stocks and ETFs up to EUR 100,000 a month. Own xStation platform.
Trading 212
Zero-commission broker with fractional shares from EUR 1 and automated investing (Pies). Suits beginners and regular investing.
Interactive Brokers
US broker for advanced investors. The widest choice of markets, low costs at larger volumes, a professional platform with a steeper learning curve.

FinSignal operates none of these platforms. We charge no commission on purchases.

Important: Signals are an analytical tool, not investment advice within the meaning of Czech Act No. 256/2004 Coll. Past performance does not guarantee future results. You make all decisions at your own risk.

§ Current signalShort-term mood

/ 100

● Slightly positive

News summary

Fresh news

Signal 27/10, 10:01

Braze se objevuje v přehledu akcií sledovaných kvůli fúzím a akvizicím; bez ověřeného obsahu nelze dovodit novou nabídku ani změnu dohody se Salesforce.

Růst ceny o 52,6 % za týden a 88,1 % za měsíc spolu s rostoucím trendem podporuje krátkodobé momentum. RSI 86 a extrémní volatilita zvyšují riziko prudkého výkyvu; převzetí zůstává podmíněné schválením.

Risks: Neschválení transakce nebo rychlý obrat po překoupeném růstu by mohl pozitivní výhled výrazně oslabit.

More about the signal

Risks: Neschválení transakce nebo rychlý obrat po překoupeném růstu by mohl pozitivní výhled výrazně oslabit.

Signal history· 2

24/1010:0173 · Strongly positive
Cena Braze za 7 dní vzrostla o 56 % a za 30 dní o 86 %; další růst by potvrdilo udržení trendu, prudký obrat by jej zpochybnil.
24/1000:0276 · Strongly positive
Salesforce podle zpráv z 22. a 23. října kupuje Braze za 5,66 miliardy dolarů; dokončení by podpořilo ocenění, schválení akcionáři a regulátory však zůstávají podmínkou.

The full 90-day signal history is part of Premium.

Ask the AI

DCF valuation

A DCF model is not suitable for this asset class.

§ Valuation check

Is the price reasonable?

Six quick tests: price against fair value, the last year, similar companies and analyst estimates. They are calculated from the numbers, not from AI estimates. This is not a recommendation.

Data 16 of 18

Valuation score

1/ 6

3/6 tests available

1. Below DCF fair value

The complete DCF range or the current price is missing.

2. Well below DCF value

The complete DCF range or the current price is missing.

3. Price vs. the last year

100% above the 1-year low (15.79 USD to 45.88 USD), based on stored daily prices.

4. P/E vs. similar companies

The sector sample has only 74 companies; scoring needs at least 8.

5. P/E relative to growth

PEG 1; a lower value means cheaper growth.

6. Analyst price target

-18.6% vs. the current price, 20 analysts.

Price and fair value

no complete range

The DCF check appears once both the price and the model range are available.

Price vs analyst target

Current price

45.84 USD

Low 30.00 USDHigh 50.00 USD

Current priceAverage: 37.30 USD

DCF gap

no complete range

The DCF check appears once both the price and the model range are available.

Analyst target

-18.6%

Average target 37.30 USD vs. price 45.84 USD.

Analyst consensus

Target range

30.00 USD - 50.00 USD

Coverage

20 analysts

Analyst consensus

1.3 / 5

Changes 180 d

+0 / -0

EPS next year

52.8%

Revenue next year

17.2%

Valuation multiples

30.6

5.7

4.1

-36.0

52-week range100% above the low

15.79 USD45.88 USD

26.0%

-13.6%

-18.5%

Price vs 50D62.9%

Price vs 200D91.5%

Metrics explained+

Price and fair value

DCF range: A model estimate of fair value from future free cash flow. A price above the range means the market pays a premium over the model; a price below it may signal a more conservative market valuation or an overly optimistic model.
Analyst target: The average and range of the analyst price targets we track. It is the market consensus, not a FinSignal recommendation, and it can lag fast price moves.
52-week range: Shows where the current price sits between the low and high of the last year. A value near the high often signals strong momentum, but on its own says nothing about whether the stock is expensive.
Price vs 50D / 200D: Compares the price with its short- and long-term moving averages. A positive value means the price is above the trend; a negative one below it.

Multiples

P/E: Price relative to current earnings. A lower P/E can mean cheaper, but it can also point to a weak outlook or risk.
Forward P/E: Price relative to next year's expected earnings. For growing companies it is often more useful than the historical P/E because it reflects estimates of future earnings.
P/B: Price relative to the book value of equity. It makes more sense for banks, insurers and capital-intensive companies than for software or brands.
P/S: Price relative to revenue. It helps with companies that have low or negative earnings; a high P/S means the market expects strong growth or future margins.
EV/EBITDA: The value of the whole company, including debt, relative to operating profit before depreciation. Useful for comparing companies with different leverage.
PEG: P/E adjusted for earnings growth. A value around 1 may suggest the valuation matches growth, but the metric is sensitive to estimates.

Growth and quality

EPS growth: Year-on-year change in earnings per share. Strong growth supports a higher valuation, but for cyclical companies it can be temporary.
Revenue growth: The growth rate of sales. It helps tell whether profits grow on real demand or mainly on cost savings.
Net margin: How much of each unit of revenue is left as net profit. A higher margin often points to stronger pricing power or more efficient operations.
ROE: Return on equity. A high ROE can signal a quality business, but check that it is not artificially boosted by heavy debt.

Most data available. Missing values mean the market data source did not provide them for this ticker. The data is indicative and may be delayed. Price as of 26/10/2026.

Management and competitive advantage

Both are estimated by the AI from the company profile, news and results. They do not count towards the 6-pillar financial health score. The AI comments are in Czech.

mixed

Spoluzakladatelé ve vedení podporují kontinuitu strategie, avšak dostupné hodnocení governance vykazuje výrazná rizika v auditu, odměňování i právech akcionářů.

strong

Platforma propojuje zákaznická data, analytiku a více komunikačních kanálů, což může zvyšovat náklady na přechod a posilovat integraci u klientů. Výhodu omezují silní konkurenti, například Salesforce a Adobe.

Information

Type: Global stock
Symbol: BRZE
Exchange: NASDAQ
Currency: USD
Sector: Informační technologie
: 3.4B USD
: 16.0 %
: 0.91

§ Risk profile

Hlavními riziky jsou silná konkurence v marketingovém softwaru, tlak na firemní rozpočty a možnost, že růst tržeb nepovede dost rychle k udržitelné ziskovosti. Český investor navíc podstupuje měnové riziko USD/CZK.

Ask the AI about Braze Inc.All signals